Recall of five batches of Bepraz Gastro Resistant Tablet 20mg (rabeprazole)

The Health Sciences Authority (HSA) would like to inform healthcare professionals of a voluntary consumer level recall of Bepraz Gastro Resistant Tablet 20mg (‘Bepraz’) initiated by the manufacturer, Sun Pharmaceutical Industries Limited. The recall is a precautionary measure due to detection of low levels of an impurity, a degradation by-product of the active ingredient rabeprazole sodium, in one batch of Bepraz. The company is recalling all five batches of Bepraz currently available in the market to prevent potential exposure of patients to elevated impurity levels. Please refer to the letter for details.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.